934
Participants
Start Date
March 25, 2021
Primary Completion Date
April 30, 2026
Study Completion Date
December 31, 2026
albumin-bound paclitaxel
Experimental:Albumin-bound paclitaxel combined with gemcitabine was administered on the first and eighth day, a cycle of three weeks Active Comparator: Albumin-bound paclitaxel combined with gemcitabine was administered on the first, eighth, and fifteenth days, with a four-week cycle
RECRUITING
Rui Liu, Tianjin
Tianjin Medical University Cancer Institute and Hospital
OTHER